About Ram Palanki
Form D filings for RevOpsis Therapeutics from 2022 to 2024 list Ram Palanki as director.
Ram Palanki first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Ram Palanki in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Ram Palanki works with at each company, as listed on that company's latest Form D.
RevOpsis Therapeutics, Inc. · Form D, Nov 7, 2024
RB
Ramanath Bhandari
Chief Executive Officer